The Role of Patient Expectations in Traumatic Orthopedic Outcomes-TEFTOM EURASIA

NCT ID: NCT01134354

Last Updated: 2014-06-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

199 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-06-30

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Design:

Prediction trial, up to 10 sites in Asia and Europe

Goal:

To better understand the "success" or "failure" after orthopedic trauma surgery by developing a model that can be applied clinically as a user-friendly "baseline" questionnaire - capable of predicting "success" or "failure" based on a patient's pre-surgical expectations of their final outcome and to validate a novel outcomes measure (TOM).

Primary aim:

To assess the psychometric properties of predictive validity, internal consistency and reproducibility of the trauma expectation factor (TEF) in the Eurasian population.

Secondary aim:

To assess the psychometric properties of criterion validity, internal consistency,reproducibility, and sensitivity to change of the TOM in the Eurasian population.

Key questions related to patient and surgeon expectations:

* How different, or similar, are patient and surgeon expectations?
* Do expectations change over time?
* Do patient expectations predict outcomes in validated measures use today?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tibia Fracture (Isolated) Ankle Fracture (Isolated)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TEFTOM

Patient outcome measure

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Isolated ankle or distal tibia fracture
* Scheduled for and undergoing one of the following surgeries for their fracture:

* Open fracture and internal fixation (ORIF)
* external fixation (EF)
* EF followed by ORIF
* 18 years of age or older
* Understand and read country national language at elementary level
* Able to understand the purpose of the clinical trial,
* Able and willing to conduct all follow-up visits
* Signed informed consent

Exclusion Criteria

* Subject has previously undergone internal fixation surgery for this ankle/distal tibia fracture.
* Subject has disease entity, or condition that precludes likelihood of bony union (e.g., metastatic cancer, metabolic bone disease).
* Subject has severe dementia or other severe mental health problem that may preclude him/her from completing study questionnaires.
* Subject is participating in other competing clinical research that may interfere with participation in this research.
* Subject is unlikely to attend study related follow-up visits.
* Subject has poly-trauma (more than one organ system compromised)
* Subject has additional fracture(s) other than ankle fracture
* Subject is a prisoner
* Fracture occurred more than 28 days before surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AO Clinical Investigation and Publishing Documentation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Reto Babst, MD

Role: PRINCIPAL_INVESTIGATOR

Luzerner Kantonsspital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen Mary Hospital

Hong Kong, , China

Site Status

Shanghai Sixth People's Hospital

Shanghai, , China

Site Status

Universitätsklinikum Köln

Cologne, , Germany

Site Status

HOSMAT Hospital

Bangalore, , India

Site Status

Hospital Universitari de Girona Doctor Josep Trueta

Girona, , Spain

Site Status

Kantonsspital Luzern

Lucerne, , Switzerland

Site Status

Stadtspital Triemli

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China Germany India Spain Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TEFTOM EURASIA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TPF Machine Learning Algorithms
NCT04983316 TERMINATED
Timing of Damage Control Orthopedic Surgery
NCT05785143 ACTIVE_NOT_RECRUITING